• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

December 18, 2024

Jacque's Post

 

(PATIENCE IS UNDERRATED WHEN YOU BECOME AN INVESTOR)

December 18, 2024

 

Hello everyone

It’s the final week before Christmas.  The market has been pausing before the Fed’s final meeting of 2024, which may be the catalyst for a year end rally.  We will wait and see. 

First, let’s look at the difference between patience and impatience.  Warren Buffet reminds us that:

“The Stock market is a device for transferring money from the impatient to the patient.”

THIS IS WHAT IMPATIENCE LOOKS LIKE IN THE INVESTMENT WORLD

 

 

When I was reviewing the portfolio and wanted to slim it down earlier this year, I recommended to sell this stock as it was underperforming at the time.  The lesson here -it is a mistake to interpret a period of underperformance as a reason to sell a stock.  My patience hat must have been missing that day.

AND THIS IS WHAT PATIENCE LOOKS LIKE IN THE INVESTMENT WORLD

 

 

CrowdStrike (CRWD) suffered a severe crash in August due to a routine update to its cybersecurity software which had a malfunction. It sent around 8.5 million Windows-based computers crashing.  The outage cost its largest customers around $5.8 billion.   But (CRWD) has recovered.

 

 

And we see a similar recovery taking place in Snowflake, after its stock dropped from $240 down to $110 in 2024.  In the spring of 2024, a string of data breaches linked to Snowflake sent a shudder through the cybersecurity community. The breach resulted in the theft of a significant volume of sensitive data from various high-profile companies.  Analysts have also argued that (SNOW) lags rivals in developing AI related products.  Add to this, a new CEO stepped into the company earlier this year.   The stock has jumped since November when investors were surprised by the financial results it reported for its fiscal third quarter of 2025.  The company had some big customer wins during Q3, which was an encouraging sign. Its customers signed longer-term contracts, and this is something that will continue to provide strong financial results in coming years.

 

WHERE BITCOIN COULD BE HEADING NEXT

 

 

Targets are $109k, $115k, $124k, $127k, $129k right up to $153k

THE PRO-BITCOIN NARRATIVE

Trump’s election promise was to establish a BTC strategic reserve and end Operation Chokepoint 2.0.   Gensler has been replaced at the SEC with a pro-crypto Chair, Other sovereign’s/nation states expected to follow suit.

The corporates have dived into Bitcoin.  Larry Fink, CEO of BlackRock, who originally ignored Bitcoin, is now a convert and sees it as an asset class.  His ETF (IBIT) was launched in January this year and had around $10 billion under management after just a few weeks.  Many tech companies are now considering treasury investment, along with 88% of S&P500 companies. 

We are seeing more institutional investment in Bitcoin, and this should continue in 2025.  Pension funds, Asset Consultants, and Global Asset Managers are now allocating to BTC to diversity Alternatives Exposure – so we could see 3% AuM as an average.

Family Offices and Retail Investors will continue to grow their exposure to BTC, either directly or via ETFs as part of a balanced portfolio included in pensions and endowments.

Crypto and Digital Assets have been legitimized as an asset class and are on track to be included across all investor portfolios.

Consider this:

Corporate Treasuries: S&P500 – 5% allocation => $40,000 increase in Bitcoin price

Institutions: Pensions & Insurance Co’s – 2.5% allocation = > $200,000 increase in BTC.

Sovereign Wealth Funds: 3% allocation => $500,000 + increase in BTC price.

 

AND WHAT ABOUT GOLD

While Bitcoin is rallying, gold is retracing.  As bond yields move up, we tend to see a retracement in gold prices, so, in general, they historically have an inverse relationship. 

 

 

Inside Edge Capital chart

As I have been saying gold has entered a correction and this could continue for some time.  We could easily see the metal drop below $2600 and move toward $2400 area and below. I have suggested selling calls on precious metals’ stocks.  Another way to play the bearish move is to buy the DB Gold Short ETF (DGZ).

QI CORNER

MARY ANN BARTELS BELIEVES WE ARE IN “THE GOLDEN AGE OF INVESTING”.

Sanctuary Wealth’s chief investment strategist thinks the market could grow by 20% next year and the S&P500 could be at around 13,000 by the end of the decade.  Below I share parts of an interview she gave at the Barron’s Women’s Advisor Summit in December at The Breakers in Palm Beach.

Why stocks can gain 20% next year.  “What I’ve studied in my 40 years is that markets don’t make a major peak until all investors are in and the market is levered.  I find that through the New York Stock Exchange margin debt and we’re not even close.  I believe between now and the end of the decade, we’re still in a secular bull market.  My forecast for next year on the S&P 500 is pretty aggressive at 7,200 to 7,400. We can get 10% or 15% pullbacks.”

Super bullish through 2030.  “I think the environment is still very bullish for the market to go up. I also introduced a target for the end of the decade for the S&P500 between 10,000 and 13,000. And that’s what I want clients and investors to focus on.  I believe between today and the end of the decade, it will be one of the most profitable investment opportunities of our lifetime.”

Reasons for optimism.  “At the end of the day, what drives stock prices is earnings, and earnings have been stronger than what most people have even anticipated.  I think we’re still trying to figure out how AI is going to impact earnings.  I think corporate profit margins will continue to grow.  The other amazing thing and why I am so bullish on technology is return on equity.  Warren Buffett always talks about return on equity, but Wall Street tends to talk more about P/E ratios.  When we look at technology versus the S&P500, the broader index has an ROE of about 18% while tech and tech related stocks’ ROE is growing 30%.”

Favourite and least favourite sectors.  “I’m very bullish on bans and capital markets.  The Trump administration is expected to have more of a deregulated environment.  M&A activity should pick up, particularly in the banks.  I think banks will do well, but I’m more positive on capital markets.  I’m negative on healthcare…Consumer staples look very weak.  But cyclicals look good and that’s a sign that the economy’s going to grow in 2025.”

Expecting more gains for Bitcoin.  “Longer term, if we create (government) reserves and make it a true form of a digital asset, it’s going significantly higher, even from where we are today…A hundred thousand dollars was where you kind of bob and weave.  Now we’ve busted through that.  So, the next target is $113,000 and the target above that is $150,000.  Those are my near-term targets.”

Advice for individual investors.  “For my entire career there’s always been some concern and what is perceived to be a reason not to invest in markets.  And history has shown that staying out of markets is not what you want to do.  If you want to grow your wealth, you have to stay invested…If you want to have retirement funds when you retire, you need to invest now and you need to stay invested.  Dollar cost average over your lifetime.”

(It seems to me that Mary Ann and I have something in common in relation to our thoughts on the markets, on staying invested and dollar cost averaging). 

SOMETHING TO THINK ABOUT

A HACKER’S ADVICE ON PROTECTING YOURSELF ONLINE

Keep all sensitive information (Passwords, seed phrases and so on) on paper and away from online 3rd party digital storage.  Don’t click on random links or download random files.

 

 

Cheers

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-18 12:00:172024-12-18 12:07:44December 18, 2024
april@madhedgefundtrader.com

Trade Alert - (TSLA) December 20, 2024 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-18 11:13:152024-12-18 11:13:15Trade Alert - (TSLA) December 20, 2024 - EXPIRATION AT MAX PROFIT
april@madhedgefundtrader.com

December 18, 2024

Diary, Newsletter, Summary

Global Market Comments
December 18, 2024
Fiat Lux

 

Featured Trade:

(TESTIMONIAL),
(WHAT EVER HAPPENED TO THE GREAT DEPRESSION DEBT?),
($TNX), (TLT), (TBT)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-18 09:06:162024-12-18 10:34:40December 18, 2024
Mad Hedge Fund Trader

Testimonial

Diary, Newsletter, Testimonials

It's so great having John as my Personal Investment 911.  Even when he was navigating the current of his excellent Summit … it took him less than 3 minutes to answer my questions & guide me on my way.  I’m underway & making hay … thank you, John.

Andy  
Sarasota, Florida

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2023/06/john-thomas-pilot.png 274 350 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-12-18 09:04:282024-12-18 10:34:15Testimonial
april@madhedgefundtrader.com

Trade Alert - (JPM) December 20, 2024 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-17 14:59:342024-12-17 14:59:34Trade Alert - (JPM) December 20, 2024 - EXPIRATION AT MAX PROFIT
april@madhedgefundtrader.com

Trade Alert - (TSLA) December 20, 2024 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-17 14:51:072024-12-17 14:51:07Trade Alert - (TSLA) December 20, 2024 - EXPIRATION AT MAX PROFIT
april@madhedgefundtrader.com

December 17, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
December 17, 2024
Fiat Lux

 

Featured Trade:

(THE BIG BATCH THEORY)

(CTLT), (DHR), (RGEN), (AVTR), (NVO), (PFE), (LLY), (MRK)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-17 12:02:532024-12-17 12:31:42December 17, 2024
april@madhedgefundtrader.com

The Big Batch Theory

Biotech Letter

If I had a nickel for every time someone said pharmaceutical manufacturing was boring, I could’ve started bidding against Novo Holdings for Catalent (CTLT) myself.

Sure, I’d still be $16.5 billion short, but you get the point—this deal is huge, and it’s about to make some smart money look even smarter.

Here’s the deal: Novo Holdings is shelling out $16.5 billion to snap up Catalent, a contract development and manufacturing organization (CDMO).

If that acronym sounds like alphabet soup, let me translate: CDMOs are where the real action happens.

These are the guys behind the curtain making sure your miracle drugs and life-saving treatments aren’t just ideas—they’re products hitting the market at scale.

The numbers don’t lie. The CDMO market sits at $146 billion right now.

Fast-forward to next year, and that balloons to $243.3 billion. By 2029, it’s cruising toward a cool $332 billion.

And if you think that’s impressive, just wait: the broader pharmaceutical outsourcing trend is nowhere near slowing down.

In 2014, Big Pharma still clung to in-house production for 66.3% of its output.

Today? That figure’s down to 51%, and dropping fast. Why? Because outsourcing lets the specialists handle the hard stuff—faster, cheaper, and more efficiently.

For investors, Catalent’s immediate upside is a no-brainer. The acquisition premium is pure gravy, but that’s not the whole story.

Rivals like Lonza Group (SWX: LONN) and Samsung Biologics are already feeling the heat.

The biologics CDMO market alone is expected to expand by $10.63 billion between 2024 and 2028, and you better believe those two are scrambling to stay ahead.

If you own shares, keep your seatbelt fastened. If you don’t, well… you might want to rethink that.

And here’s where it gets really interesting: Novo Holdings may be private, but its publicly traded golden child, Novo Nordisk (NVO), is set to ride this wave like a pro surfer.

They’re already a global powerhouse in biologics, and Catalent’s souped-up manufacturing capabilities are going to help them scale production with military-grade efficiency.

Lower costs, tighter operations, bigger margins—it’s like handing a Formula 1 car to an already championship-winning team.

So if you’re not watching Novo Nordisk stock, you’re doing it wrong.

Of course, it’s not just the big CDMO players who stand to win here. Companies like Danaher (DHR), Repligen (RGEN), and Avantor (AVTR) are quietly cashing in on this gold rush.

These firms supply the picks, shovels, and critical bioprocessing tools that CDMOs need to keep production humming.

As Catalent scales under Novo Holdings, demand for these essentials will go through the roof.

Zooming out, the pharma manufacturing landscape is evolving at a breakneck pace.

The CDMO market is expected to hit $530.3 billion by 2033, growing at a steady 7.7% CAGR.

That’s not speculative growth—it’s a structural shift, backed by demand for biologics, gene therapies, and personalized medicine.

In short, we’re entering an era where outsourcing is king, and companies with the infrastructure to capitalize on it are poised to dominate.

Don’t forget about the big dogs in Big Pharma, either.

Pfizer (PFE), Eli Lilly (LLY), and Merck (MRK) aren’t just spectators in this game. They’re snapping up CDMO capacity, investing in biologics, and doubling down on therapies with blockbuster potential.

The Catalent deal is just the latest chess move in a game where the stakes keep getting higher.

So what does this mean for you? If you’re holding Catalent, congratulations—your portfolio is about to get a nice bump.

But the real play here isn’t Catalent alone. It’s understanding that CDMOs, suppliers, and adjacent players are the unsung heroes of this industry transformation.

You want exposure to the companies enabling the next wave of medical innovation? This is where you look.

Novo Holdings just threw down the gauntlet, and the smart money is already moving. The pharmaceutical manufacturing sector isn’t boring—it’s booming.

So, while everyone’s chasing flashy biotech startups and blockbuster drugs, the real smart money is quietly following the companies that make those breakthroughs possible.

Catalent isn’t just a $16.5 billion deal—it’s proof that outsourcing is the new backbone of pharma’s future. Call it “The Big Batch Theory:” scale up, outsource smart, and watch the returns multiply.

Ignore this shift, and you’re leaving money on the table.

Now, if you’ll excuse me, I need to check my CDMO positions. Just like a perfectly run batch, they’re growing fast—and that’s exactly how I like it."

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-17 12:00:542024-12-17 12:31:20The Big Batch Theory
april@madhedgefundtrader.com

Trade Alert - (PANW) December 17, 2024 - SELL - TAKE PROFITS

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-17 11:25:532024-12-17 11:25:53Trade Alert - (PANW) December 17, 2024 - SELL - TAKE PROFITS
april@madhedgefundtrader.com

December 17, 2024

Diary, Newsletter, Summary

Global Market Comments
December 17, 2024
Fiat Lux

 

Featured Trade:

(I’M TAKING OFF FOR THE YEAR)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-12-17 09:06:412024-12-17 10:20:41December 17, 2024
Page 6 of 14«‹45678›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top